Clinical Trial Update: A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial assessing tacrolimus versus Prograf in renal transplantation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant

Drugs mentioned

• Prograf (Tacrolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: EMS | Conditions: Renal Transplant | Phase 3 | Status: WITHDRAWN